EMA includes rare spinal condition as effect of AstraZeneca’s Covid vaccine

A European medicines regulator safety panel on Friday recommended adding a rare spinal inflammation called transverse myelitis as a side effect to AstraZeneca’s Covid-19 vaccine. The vaccine has faced several …

Read more

J&J Vaccine Gets Extra Warning About Bleeding Side Effect

US regulators have reviewed the Covid-19 Vaccine Fact Sheet from Johnson & Johnson to warn of the risk of a rare bleeding disorder. The Food and Drug Administration said in …

Read more

Latam Airlines announced that seven flights scheduled for today were canceled

The airline Latam Airlines announced that, due to the increase in cases reported by the omicron variant, and due to the contagion of crew members, seven flights scheduled for today …

Read more

These are the seven main predictions for the new year in terms of technology

A new year begins and several experts predict that 2022 will be a year with many changes and evolutions in terms of technological advances that could change everyday life. These …

Read more

Microsoft joins Google and Amazon in canceling people’s attendance at CES

The company joins a list of companies that choose not to have a physical presence in the next month. event on concerns about the rapid spread of the omicron variant. …

Read more

Latin America is now the world leader in vaccinations and deaths from covid fall

Once a hot spot for COVID-19 deaths, Latin America now outstrips the United States and much of the world in vaccinations as supply concerns have eased and health policymakers rush …

Read more

Colombian peso is the most devalued currency in Latin America in the last month

The Colombian peso is the most devalued currency in the region in the last month, with a fall of 5.99% since last October 29. According to Bloomberg data, the Mexican …

Read more

Moderna says Omicron vaccine could be ready by early 2022

Moderna Inc.’s chief medical officer, Paul Burton, said he suspects that the new variant of the omicron coronavirus may elude current vaccines, and if so, a reformulated injection could be …

Read more

MinSalud announced that 11 million vaccines are ready for the booster dose


Last Tuesday, November 23, the Ministry of Health confirmed that the application of booster doses would begin for the population between 18 and 49 years old. This announcement was made a few days after opening the immunization phase for people over 50 years of age who have completed four months after completing their scheme.

With these new measures, the Government seeks to mitigate the impact that is expected with the fourth peak and for this, the head of the Health portfolio, Fernando Ruiz, assured that the country has the capacity to supply the application of vaccines, for those who do not they have the first dose, for those who need to complete the entire scheme and, also, for those who already require the booster dose.

Once the vaccines are assured, the Ministry explained that the application time for the reinforcement will be six months after the last dose, and according to how the stages of the National Vaccination Plan are developed, “of the first group vaccinated of Stage 1 and Stage 2 The six months have already passed and, therefore, they would be getting vaccinated as of today, ”Ruiz said Tuesday.

In line with this, the minister stressed that the Vaccine Advisory Committee also recommended applying the doses heterologously, since as explained by Areandina epidemiologist Ángel Muegues, this strategy, which consists of applying a different vaccine, seeks to maximize the mechanisms against a virus. “It can trigger complementary responses in the immune system; mixing vaccines has been shown to produce higher antibody titers than with a single type of vaccine ”.

Thus, those who have been vaccinated with Pfizer and Moderna, can apply AstraZeneca since it is a viral vector, while those who have Sinovac can with any of the above, except Pfizer to give priority to pregnant women.

It should be noted that Moderna and Pfizer announced that the US Food and Drug Administration (FDA) extended the authorization of emergency use of the booster dose of the anticovid booster vaccine for all adults over 18 years of age.

Read more

Conflict of interests in the Board of Directors of Grupo Sura would delay decision on takeover bid

Before the Public Acquisition Offer (OPA) for Nutresa, the largest shareholders of the food company (Grupo Sura and Grupo Argos) began to analyze the options to make a decision. Sura …

Read more